Production and characterization of monoclonal antibodies specific for Leptospira borgpetersenii serovar hardjo type hardjobovis and Leptospira interrogans serovar hardjo type hardjoprajitno
O. Surujballi et al., Production and characterization of monoclonal antibodies specific for Leptospira borgpetersenii serovar hardjo type hardjobovis and Leptospira interrogans serovar hardjo type hardjoprajitno, CAN J VET R, 63(1), 1999, pp. 62-68
Citations number
39
Categorie Soggetti
Veterinary Medicine/Animal Health
Journal title
CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE
Murine monoclonal antibodies were produced by immunizing BALB/c mice with a
killed whole-cell antigen prepared from Leptospira borgpetersenii serovar
hardjo type hardjobovis. Six of these antibodies recognized epitopes on the
homologous antigen and on whole-cell antigen prepared from Leptospira inte
rrogans serovar hardjo type hardjoprajitno. These antibodies did not cross-
react with whole-cell antigens prepared from L. borgpetersenii serovar sejr
oe, 10 other pathogenic Leptospira serovars, or the saprophytic Leptospira
biflexa serovar patoc. Three other monoclonal antibodies reacted with antig
ens prepared from the 2 hardjo serovars and serovar sejroe but not with ant
igens from the 10 other pathogenic serovars, or serovar patoc. The epitopes
recognized by all of the hardjo-specific antibodies and 2 of the 3 hardjo/
sejroe-specific antibodies were susceptible to sodium meta-periodate oxidat
ion, All of the antibodies were characterized by Western blots with the har
djobovis whole-cell antigen. Each of the 9 monoclonal antibodies was inhibi
ted from binding to the hardjobovis antigen by bovine sera which were obtai
ned from cattle experimentally infected with hardjobovis and from field cat
tle, with anti-serovar hardjo microscopic agglutination test antibody titre
s ranging from 100 to 12 800. Some of these antibodies may be suitable for
incorporation into competitive enzyme immunoassays for the specific detecti
on of antibodies to either of the hardjo serovars.